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ABSTRACT
Objective To evaluate the diagnostic accuracy of intracranial translucency (IT) in the detection of spina biﬁda (SB) in
the ﬁrst trimester of pregnancy.
Methods We included study assessing the accuracy of sonographic measurements of IT in a mid-sagittal view of the
fetal face in prediction of SB in the ﬁrst trimester of pregnancy. The primary outcome was the accuracy of IT in
prediction of spina biﬁda. Summary estimates of sensitivity, speciﬁcity, positive and negative likelihood ratios (LR),
and diagnostic odds ratio for the overall predictive accuracy of IT were computed.
Results Nine studies (21 070 fetuses) were included in the analysis. IT was successfully assessed in the majority of
fetuses 97.8% (95% CI 97.6–98.0). The diagnostic performance of IT in detecting SB was as follows: sensitivity: 53.5%
(95% CI 42.4–64.3), speciﬁcity: 99.7% (95% CI 99.6–99.8), positive LR: 62.1 (95% CI 12.2–317), negative LR:0.55 (95%
CI 0.45–0.68), and diagnostic odds ratio: 223 (95% CI 25–2039).
Conclusions Intracranial translucency had low diagnostic accuracy in prediction of open spina biﬁda, thus
questioning its role as a screening marker for open SB in an unselected population. When looking at the individual
study data, it appears that IT assessment for open SB prediction can be affected by a high rate of false positive results
potentially leading to unnecessary parental anxiety. © 2016 John Wiley & Sons, Ltd.
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INTRODUCTION
The incidence of neural tube defects, including spina biﬁda
(SB), is about 1.4/1000 live births.1
An ultrasound prenatal diagnosis of SB may be achieved in
the second trimester by identifying indirect signs (e.g. the
‘lemon sign’ and the ‘banana sign’) as well as by examining
the spine in order to visualize the lesion.2 Several signs have
been used for the detection of SB, including fetal biparietal
diameter, frontomaxillary facial angle, and other
craniocerebral signs, but they had low sensitivity and
speciﬁcity. In the ﬁrst trimester, both the spine lesion and the
indirect signs are rarely identiﬁed, and this could lead to a
delayed diagnosis.3 Several ultrasonography markers,
including intracranial translucency (IT), have been considered
for the detection of SB at 11 to 14weeks (Figure 1),3 but no
consensus has been reached on the diagnostic accuracy of
these markers.
The aim of this systematic review and meta-analysis was to
evaluate the accuracy of sonographic measurements of IT in
the detection of SB in the ﬁrst trimester of pregnancy.
METHODS
Study identiﬁcation and selection
This review was performed according to a protocol designed a
priori and recommended for systematic review.4 Electronic
databases (MEDLINE, PROSPERO, Scopus, ClinicalTrials.gov,
EMBASE, Sciencedirect, the Cochrane Library, and Scielo)
were searched from their inception until March 2016 with no
limit for language. Search terms used were the following text
words separately and also in combination: ‘sonographic’,
‘ultrasound’, ‘fetal’, ‘pina biﬁda’, ‘screening’, ‘ﬁrst trimester’,
‘nuchal’, ‘pregnancy’, ‘intracranial translucency’, ‘2D’, ‘3D’,
‘accuracy’, ‘prediction’, ‘brain stem’, ‘cisterna magna’,
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‘fossa’, ‘neural tube defect’, ‘obstetric’, ‘cohort study’,
‘randomized’, ‘case-control’, ‘studies’, ‘meta-analysis’,
‘metaanalysis’, ‘systematic review’, ‘posterior’, and ‘review’.
No restrictions for language or geographic location were
applied. In addition, the reference lists of all identiﬁed
articles were examined to identify studies not captured by
electronic searches. The electronic search and the eligibility
of the studies were independently assessed by two authors
(GS and FDA). Differences were discussed and consensus
reached.
We considered case–control and cohort studies. Studies
were included if they reported data allowing construction
of a 2 × 2 contingency table. We included only studies
assessing the accuracy of sonographic measurements of IT
in a mid-sagittal view of the fetal face in prediction of SB
in the ﬁrst trimester of pregnancy (i.e. ≤14weeks). The test
(i.e. sonographic measurements of IT) was considered
positive if IT was not visible or below the cut-off as deﬁned
by the original study. Case reports, case series with less
than three cases and conference abstracts were excluded.
Studies in women with multiple gestations were also
excluded. The primary outcome was the accuracy of IT in
prediction of SB.
Data abstraction and methodological quality assessment of
the included studies were completed by two independent
investigators (GS and FDA). Each investigator independently
abstracted data from each study separately. Data from each
eligible study were extracted without modiﬁcation of original
data onto custom-made data collection forms. Disagreements
were resolved by consensus with a third reviewer (GMM). All
authors of the original studies were contacted for missing data
if possible.
The quality assessment of each included study was
assessed by using Quality Assessment of Diagnostic
Accuracy Studies criteria.5 The meta-analysis was reported
following the preferred reporting item for systematic reviews
and meta-analyses statement.6 Before data extraction, the
review was registered with the PROSPERO International
Prospective Register of Systematic Reviews (registration no.:
CRD42016037905). The study was performed in accordance
with the SEDATE guideline.4
Statistical analysis
For all the included studies, we constructed a 2 × 2 table
cross-classifying ultrasound measurement of IT and the
prediction of SB in the ﬁrst trimester. Summary estimates
of sensitivity, speciﬁcity, positive and negative likelihood
ratios (LR+ and LR), and diagnostic odds ratio (DOR) for
the overall predictive accuracy of IT in detecting spina
biﬁda during the ﬁrst or second trimester were computed
by using the hierarchical summary receiver operating
characteristics (HSROC) model.6 Rutter and Gatsonis HSROC
parameterization was used because it models functions of
sensitivity and speciﬁcity to deﬁne a summary ROC curve,
Figure 1 Ultrasound image in the mid-sagittal plane of the fetal face in case of open spina biﬁda demonstrating compression of the fourth
ventricle with no visible intracranial translucency (a) and in case of normal fetal brain structure (b). The occipital bone is highlighted by the
white arrow. Blue, midline structure of the brain with the mesencephalon; yellow, forth ventricle with intracranial translucency; red, cisterna
magna; yellow dashed line, nuchal translucency. Nuchal translucency 2.5mm (A) and 2.4mm (B). The ultrasound scan was obtained by one
of the reviewers (GMM) at our department (Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University
of Naples Federico II, Naples, Italy)
G. M. Maruotti et al.992
Prenatal Diagnosis 2016, 36, 991–996 © 2016 John Wiley & Sons, Ltd.
and its hierarchical modeling strategy can be used for
comparisons of test accuracy when there is variability in
threshold between studies.7
The DOR is deﬁned as the ratio of the odds of the test being
positive if the subject has a disease, relative to the odds of the
test being positive if the subject does not have the disease, that
is, LR+/LR.8
Potential publication bias was formally assessed through
Egger’s regression asymmetry test. Following speciﬁc
indications for meta-analyses of diagnostic accuracy, we
correlated individual study sample sizes with both sensitivity
and speciﬁcity as measures of test accuracy.9
Stata command metandi (Stata Corp., College Station, TX,
USA; 2013) was used to analyze the data.
RESULTS
The ﬂow of study identiﬁcation is shown in Figure 2.
Supplementary File S1 shows the full electronic search from
the major database (i.e. MEDLINE). Sixteen studies
evaluating the sonographic detection of SB in the ﬁrst
trimester in singleton gestations were assessed for the
eligibility.3,10–24 Seven of them were excluded.3,11,12,15,22–24
Two were excluded because IT was not evaluated12,15; two
were excluded because they were case series3,11; Liu et al.
was excluded because they used women without IT
measurement as controls,22 while two were excluded due
to lack of data allowing construction of a 2 × 2 table.23,24
Nine studies including 21070 fetuses undergoing ﬁrst
trimester assessment of IT were included in the systematic
Figure 2 Flow diagram of studies identiﬁed in the systematic review. IT, intracranial translucency
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review.10,13,14,16–21 The overall prevalence of spina biﬁda was
0.21% (95% CI 0.2–0.3; 45/21070). Figure 3 shows the results
of the quality assessment. The overall risk of bias was low.
None of the included studies had high risk of bias in
‘patient selection’ and ‘index test’.
Table 1 shows the characteristics of the nine included
studies.
Six were retrospective studies,10,13,16,18–20 and three were
prospective studies.14,17,21 Six were cohort studies,10,13,16–18,21
while three were case–control studies.14,19,20 All the included
Figure 3 Review authors’ judgment of risk of bias and applicability concerns based on Quality Assessment of Diagnostic Accuracy Studies
tool. (A) Summary of risk of bias for each study: plus sign, low risk of bias; minus sign, high risk of bias; question mark, unclear risk of
bias. (B) Risk of bias graph about each risk of bias item presented as percentages across included studies. Green, low risk of bias; red, high risk
of bias; yellow, unclear risk of bias
Table 1 Characteristics of the included studies
Author Year Country Study design
Type of
scan Reference standard IT cut-off
Sample
size (n)
Spina
biﬁda (n)
Chen 2015 Germany Prospective cohort
study
Not stated Post-natal charts <1st
percentile
16 164 11
Mangione 2013 France Retrospective
case–control study
Not stated Pathology report (TOP) Absent IT 260 8
Garcia-
Posada
2013 Spain Retrospective
case–control study
TA Post-natal charts <5th
percentile
85 5
Adiego 2012 Spain Prospective cohort
study
TA and TV Second-trimester scan or post-
natal charts
Absent IT 990 1
Kavalakis 2012 Greece Retrospective
cohort study
TA and TV Post-natal charts Absent IT 1331 3
Fong 2011 Canada Retrospective
cohort study
TA and TV Post-natal charts Absent IT 199 8
Scheier 2011 Austria, Czech
Republic, and UK
Prospective
case–control study
TA Post-natal charts Absent IT 13 3
Iliescu 2011 Romania–Greece Retrospective
cohort study
TA and TV Pathology report (TOP) Absent IT 1824 2
Chaoui 2009 Germany Retrospective
cohort study
Not stated Second trimester ultrasound Absent IT 204 4
IT, intracranial translucency; TA, transabdominal; TV, transvaginal.
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studies assessed the IT validity in screening for open SB (OSB)
at the same gestational age (i.e. 11–13weeks) by using a mid-
sagittal view of the fetal face. No study reported data for
closed SB. In all but two studies,20,21 the test (i.e. IT
measurement) was considered positive if IT was not visible,
while in Garcia-Posada et al., the test was positive if the
anteroposterior diameter of the fourth ventricle was <5th
percentile according to crown-rump length20; in Chen et al.,
it was <1st percentile.21 The method of ultrasound
ascertainment was clearly described in all the individual
studies. In all of the included studies, the defect was
conﬁrmed after the delivery by neurological examination of
the newborn.
Intracranial translucency was successfully assessed in the
majority of fetuses (97.8%, 95% CI 97.6–98.0). The diagnostic
performance of IT in detecting spina biﬁda was computed by
using the HSROC model (Figure 4); diagnostic performance
was as follows: sensitivity: 53.5%, 95% CI 42.4 to 64.3;
speciﬁcity: 99.7%, 95% CI 99.6 to 99.8; LR+: 62.1, 95% CI
12.2 to 317; LR: 0.55, 95% CI 0.45 to 0.68; and DOR: 223,
95% CI 25 to 2039. The ﬁgure for the diagnostic accuracy of
the individual studies is reported in as Supplementary File S1.
DISCUSSION
Main ﬁndings
The ﬁndings from this systematic review showed that ﬁrst-
trimester transabdominal sonographic measurements of IT
can be accomplished in the large majority of fetuses. IT
had low diagnostic accuracy in prediction of OSB with a
sensitivity of 53.5%, 95% CI 42.4 to 64.3, thus questioning
its role as a screening marker for OSB in an unselected
population. The speciﬁcity of IT in prediction of OSB was
>99%.
Strengths and limitations
The limitations of our study are inherent to the limitations of
the included studies. The quality of the ﬁndings is dependent
on the quality of the primary studies included. The number
of the included women as well as the number of the included
studies were limited. These were generally small-sized studies
due to the low incidence rates. Individual studies showed great
differences in sample size. The generalizability and the external
validity of these ﬁndings may be limited due to the high quality
of ultrasound employed at these institutions and the patient
population evaluated.
Implications for clinical practice
Many of major fetal abnormalities can be diagnosed prenatally
by ultrasound.25,26 Some of these abnormalities can be
detected in the ﬁrst trimester during the 11 to 13weeks’ scan;
others may be suspected in the ﬁrst and then conﬁrmed in
the second trimester scan. Apart from IT thickness/presence,
other signs and ratios in the ﬁrst-trimester posterior brain have
also been used for the detection of SB, including fetal biparietal
diameter, frontomaxillary facial angle, and other
craniocerebral signs.3,27–29 Usually, prenatal diagnosis of
OSB is carried out by ultrasound examination in the second
trimester of pregnancy.1,2,25,26 Being able to predict OSB
earlier has several potential beneﬁts, and failure to detect it
may be associated with higher rates of neonatal morbidity
and mortality.30,31 In most countries, parents whose fetus is
diagnosed with OSB usually opt for termination of
pregnancy. An early detection may give the parents more
time for decision-making or allow earlier intervention.31
Providers and birth locals may be able to better plan staff
and coverage.31,32
In the same mid-sagittal view of the fetal face routinely used
at the 11 to 13weeks in screening for chromosomal defects, the
anteroposterior diameter of the fourth ventricle may be
assessed.33 The fourth ventricle presents as an intracranial
translucency parallel to the standard nuchal translucency and
is delineated by two echogenic borders: the dorsal part of the
brain stem anteriorly and the choroid plexus of the fourth
ventricle posteriorly (Figure 1).33 In the normal fetuses, the
fourth ventricle was always visible, while in the fetuses with
OSB, the ventricle has been compressed by the caudally
displaced hindbrain, and this could lead to a reduce or to a
not visualization of the IT even when the cisterna magna is
visible (Figure 1). The IT could also be not visible for low-
quality scan, and this could explain why the pooled speciﬁcity
was less than 100%. However, in this case, the sonographer
must be alerted to the possibility of an underlying OSB and
undertake detailed examination of the fetal spine.
CONCLUSION
When looking at the individual study data, it appears that IT
assessment for OSB prediction can be affected by a high rate
Figure 4 Hierarchical summary receiver operating characteristics
curves of diagnostic performance of IT in detecting open spina
biﬁda in the ﬁrst trimester of pregnancy. Curves from receiver
operating characteristics model contain a summary estimate (■)
representing summarized sensitivity and speciﬁcity point estimates
for individual study estimates (95% CI)
Intracranial translucency in detecting spina biﬁda 995
Prenatal Diagnosis 2016, 36, 991–996 © 2016 John Wiley & Sons, Ltd.
of false positive results potentially leading to unnecessary
parental anxiety. The ﬁndings from this systematic review
do not suggest the use of IT as a screening test for OSB
during the 11 to 14 weeks’ scan in the general population.
Further, large prospective studies are needed in order to
build ultrasound predictive models able to reliably identify
fetuses at high risk for OSB during the ﬁrst trimester of
pregnancy.
In summary, IT had low diagnostic accuracy in prediction of
OSB, thus questioning its role as a screening marker for OSB in
an unselected population.
WHAT’S ALREADY KNOWN ABOUT THIS TOPIC?
• Several ultrasonographymarkers, including intracranial translucency,
have been considered for the detection of spina biﬁda at 11 to
14weeks, but no consensus has been reached on the diagnostic
accuracy of these markers.
WHAT DOES THIS STUDY ADD?
• Intracranial translucency had low diagnostic accuracy in prediction
of open spina biﬁda, thus questioning its role as a screening marker
for open spina biﬁda in an unselected population.
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